Ella Instrument- Automated Immunoassay Machine acquisition

The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to acquire an Ella Automated Immunoassay System for the Translational Neuroradiology Section (TNS). The system will be used for multiplexed, protein-based analysis of serum and plasma samples to quantify biomarkers such as neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP). The system should have minimal sample volume requirements and superior analytical precision. The objective is to correlate biomarker expression patterns with clinical parameters, disease phenotypes, and treatment responses. Key features of the system include: • ELISA workflow immunoassay • All-in-one desktop computer with Windows operating system • Simple Plex Runner and Explorer software • 1 verification cartridge • Results in less than 90 minutes • High reproducibility • Biomarker detection • Automated • 4+ logs of dynamic range • Benchtop • Requires just 25 µL of sample • Eliminates cross-reactivity by detecting each analyte in separate parallel channels • Short hands-on prep time • Zero pipetting error • Consistency in results • One year warranty • Training • Simple Plex demo kit cartridge